Goodrx is trading 5.4% up at $3.68 in pre-market on November 2; broader market gains may be contributing, but no clear company-specific announcement surfaced.

  • The price compares with the October 30 close of $3.49.
  • The Nasdaq Composite is up 0.75% and the S&P 500 is up 0.44% in the provided market context.
  • Q3 results are anticipated around November 3–4, but the report is not a confirmed catalyst for this move.